State Ledger
Company profile

ADIAL PHARMACEUTICALS, INC. CIK 1513525

Ticker
ADIL (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Charlottesville, VA 22901
Fiscal year end
2025 (FY)
Market Data
Close
$3.77
Change
-$0.21
Change %
-5.28%
Volume
729

ADIL · trading date Oct 12, 2026 · previous close $3.98 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$7.98M
Total assets
$6.67M
Total liabilities
$1.40M
Stockholders' equity
$5.28M
Cash & equivalents
$5.88M
Operating income
-$7.80M
Operating cash flow
-$6.49M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-05. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
20.9%
Equity / assets
79.1%
CapEx / revenue
—
Operating cash flow / net income
0.81×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$7.98M $6.67M $1.40M $5.28M
2024 — -$13.20M $5.04M $975.9K $4.07M
2023 — -$5.12M $4.74M $653.1K $4.08M
2022 — -$12.73M $5.73M $2.46M $3.28M
2021 — -$19.42M $7.47M $3.97M $3.51M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form DEFA14A
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-05

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Charlottesville, VA 22901
1180 SEMINOLE TRAIL
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:00 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Virginia — Public Companies